| 000 | 03785nam a22004335i 4500 | ||
|---|---|---|---|
| 006 | a||||fo|||| 00| 0 | ||
| 007 | cr nn nnnaamaa | ||
| 999 |
_c329486 _d329486 _x1 |
||
| 001 | 329486 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230102114414.0 | ||
| 008 | 201021s2020 paua o |||| 0|eng d | ||
| 020 | _a9789811575907 | ||
| 024 | 7 |
_a10.1007/978-981-15-7590-7 _2doi |
|
| 040 |
_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC |
||
| 050 | 4 |
_aQH506 _b2020 EB |
|
| 100 | 1 |
_aKumara Behera, Basanta _4http://id.loc.gov/vocabulary/relators/aut _999441 |
|
| 245 | 1 | 0 |
_aCompetitive Strategies in Life Sciences _cby Basanta Kumara Behera, Ram Prasad, Shyambhavee Behera |
| 264 | 1 |
_aSingapore _bSpringer Singapore _bImprint: Springer _c2020 |
|
| 300 | _a1 recurso en línea (XV, 189 páginas) | ||
| 336 |
_2rdacontent _aTexto _btxt |
||
| 337 |
_2rdamedia _aelectrónico _bc |
||
| 338 |
_2rdacarrier _arecurso electrónico _bcr |
||
| 347 |
_atext file _bPDF |
||
| 490 | 0 |
_aNew Paradigms of Living Systems _x2662-348X _v1 |
|
| 490 | 0 | _aBiomedical and Life Sciences (SpringerNature-11642) | |
| 490 | 0 | _aBiomedical and Life Sciences (R0) (SpringerNature-43708) | |
| 505 | 0 | _aChapter 1. Strategies in Life sciences -- Chapter 2. Management and Manufacturing process of biologics -- Chapter 3. Downstream processes -- Chapter 4. Bioprinting -- Chapter 5. Biopharmaceuticals: New Frontier. | |
| 520 | 3 | _aTailoring of biomolecules using protein engineering technology, and host cells culture techniques are among the most sophisticated and elegant achievements of modern applied life sciences in which the basic fundamentals biotechnology are applicable for the development and manufacturing of biologics and other related bio-molecules for a hurdle free life with good health. A majority of biologics derived from genetically modified host cells in the current market are bio-formulation such as antibodies, nucleic acid products and vaccines. Such bio-formulations are developed mainly in two steps i.e. upstream process and downstream process. The first volume of this series begins with the latest information on how the classical stepwise host cells culture (mammals, animals, plants, and bacteria) methodology has been changed to fully continuous or partially continuous host cells culture process in order to economise the biopharmaceutical products manufacturing process. In addition this volume narrates a brief history on conceptual development of new thoughts in designing biotechnology industries for commercial production of variety of therapeutic proteins with structural modification on the basis of clinical requirements. The readers will feel exited by going through the latest discovery and development in applied life sciences for designing innovative biomolecules for health care with utmost safe. The most interesting part of this volume is newly developed concept on bioprinting. It explains how to design and fabricate animate objects by fusing or depositing material of interest in the form of powders, solid dusts, metal, liquid or even living cells or tissues by layers to produce 3D objectives. The first volume ends with the latest information on the current trend in biologics market, market dynamic, drives, and opportunities with challenges. | |
| 988 | _aSpringer_BiomedLife_dic2020 | ||
| 650 | 7 |
_2embne _aBiología molecular _9139103 |
|
| 710 | 2 | _aSpringerLink | |
| 773 | 0 | _tSpringer Nature eBook | |
| 776 | 0 | 8 |
_iPrinted edition: _z9789811575891 |
| 776 | 0 | 8 |
_iPrinted edition: _z9789811575914 |
| 776 | 0 | 8 |
_iPrinted edition: _z9789811575921 |
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-981-15-7590-7 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 942 |
_2lcc _cLE |
||
| 998 |
_b01/2021 _dz _eh _zSI |
||